期刊文献+

醛固酮与肺心病患者肺动脉高压的关系 被引量:2

Relationship of phathogenesis between aldosterone and pulmonary hypertension in chronic pulmonary heart disease
下载PDF
导出
摘要 目的:研究血浆醛固酮浓度对肺动脉高压的影响。方法:110例慢性阻塞性肺病患者分为肺心病组与慢阻肺组,比较两组之间及与对照组间的血浆醛固酮浓度;分析血浆醛固酮浓度与肺动脉压力的关系。结果:肺心病组血浆醛固酮浓度为(101.53±117.44)ng/L,显著高于慢阻肺组的(54.14±36.90)ng/L及健康组的(60.38±43.13)ng/L;血浆醛固酮浓度与肺动脉压力的相关性分析显示血浆醛固酮浓度与肺动脉高压的呈线性正相关关系(r=0.05,P<0.05);logistic回归分析显示血浆醛固酮浓度与肺动脉高压正相关(r=1.355,P<0.05)。结论:醛固酮增多是肺动脉高压的危险因素。 Objective:To investigate the relationship between the Plasma aldosteron levels and pulmonary hypertension. Methods:1) 110 cases COPD patients were divided into two groups according to whether or not with chronic cot pulmonale. They were called COPD group and chronic cot pulmonale group. Plasma aldosteron levels were monitored in 110 cases COPD patients and healthy individuals. 2) Regression was analyzed between plasma aldosteron levels and pulmonary tension. 3) logistic Regression was analyzed between plasma aldosteron levels and pulmonary hypertension. Results: 1)The result showed that the level of plasma aldosteronwas significantly higher in chronic cot pulmonale groups than that in two other groups (P〈0.05). 2) Linear correlation showed plasma aldosteron levels was positively correlated with pulmonary hypertension (r=0.05, P〈0.05). 3) Logistic Regression showed plasma aldosteron levels was positively correlated with pulmonary hypertension (r=1.355, P〈0.05). Conclusion:Plasma aldosteron is one of the harmful factors in pulmonary hypertension.
出处 《温州医学院学报》 CAS 2006年第4期353-355,共3页 Journal of Wenzhou Medical College
关键词 醛固酮 肺动脉高压 慢性肺原性心脏病 Aldosterone pulmonary hypertension pulmonary heart disease
  • 相关文献

参考文献8

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2王铁生,段生福.慢性肺动脉高压患者肾素—血管紧张素—醛固酮系统...[J].中华内科杂志,1990,29(7):432-434. 被引量:4
  • 3Lahera V, Cachofeiro V, Balfagon G, et al. Aldosterone and its blockade: a cardiovascular and renal perspective[J]. Scientific World Journal, 2006, 6:413-24. Review.
  • 4Zhou G ,Kandala JC ,Tyagi S ,et al. Effects of angiotensin Ⅱ and aldosterone on collagen gene teroneon collagen gene expression and protein turn over in cardiac fibroblasts[J].Molcellbiochem, 1996,154(2): 171 - 178.
  • 5Cittadini A, Serpico R, Monti M, et al. The role of aldosterone in the development of postinfarction fibrosis[J]. Ital Heart J,2005, 6 (Suppl 1 ):43s-50s.
  • 6赵力,赵鸣武,方秋红,顾国忠,唐朝枢.安体舒通减轻博莱霉素A5引起的大鼠肺纤维化[J].中华结核和呼吸杂志,1998,21(5):300-302. 被引量:29
  • 7Campbell SE, Janicki JS, Matsubara BB, et al. Myocardial fibrosis in the rat with mineralocortid excess: Prevention of scarring by a miloride[J]. Am J Hypertens,1993,6 (6 Pt 1):487-495.
  • 8Struthers A. Aldosterone in heart failure: pathophysiology and treatment[J]. Curr Heart Fail Rep, 2004, 1(4): 171-175.

二级参考文献1

  • 1关尚博,全国第五次肺心病专业会议资料汇编,1987年

共引文献5133

同被引文献54

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 2Proceeding of 3nd World symposium on pulmonary arterial hypertension. Venice, Italy, June 23-25,2003[J]. J Am Coil Cardiol, 2004, 43 (2 Suppl S) : 1S-90S.
  • 3Diagnosis and management of pulmonary arterial hypertension: ACCPevidence-based clinical practice guidelinesE J]. Chest, 2004, 126 ( Suppl 1 ) : 7S-10S.
  • 4Gali N, Torbieki A, Barst A, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the european society of cardiology [ J ]. Eur Heart J, 2004, 25 ( 24 ) : 2243-2278.
  • 5McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects [ J ]. Circulation, 2001, 104 (23) : 2797-2802.
  • 6Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound [ J ]. J Am Coil Cardiol, 1985, 6(2) : 359-365.
  • 7Bradford CN, Ely DR, Raizada MK. Targeting the vasoproteetive axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy [J]. Curr Hypertens Rep, 2010, 12(4) : 212-219.
  • 8Fiebeler A, Muller DN, Shan E, et al. Aldosterone, nineralocecficoid receptors, and vascular inflammation [ J ] . Curr Opin Nephrol Hypertens, 2007, 16(2) : 134-142.
  • 9Yamanaka R, Otsuka F, Nakamura K, et al. Involvement of the bone morphogenetic protein system in endothelin and aldosterone- induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension [J]. Hypertens Res, 2010, 33(5) : 435-445.
  • 10Leopold JA, Dam A, Maron BA, et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphatede hydrogenase activity [J]. Nat Med, 2007, 13(2) : 189-197.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部